Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model

FEBS Open Bio(2023)10.1002/2211-5463.13625Source: DataRank Database

CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model is a research paper published in FEBS Open Bio (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.03)OA: goldTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jihong Ma,Huiping Zhang ORCID,Rashmi Ramakrishna,Danielle Mintzlaff,David W. Mathes ORCID

Live enrichment

PubMed:37157185 OpenAlex:https://openalex.org/W4375954613

National Institutes of Health

Grant: 1R42CA261547‐01

National Institutes of Health

Grant: U01HL152405

NCI NIH HHS

Grant: R42 CA261547

FWCI

3.03

Citation Percentile

0.9%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.13625

GOLDhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.13625

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.13625

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.13625

journalhttps://doi.org/10.1002/2211-5463.13625

Fields of Study

Cutaneous lymphoproliferative disorders researchCAR-T cell therapy researchLymphoma Diagnosis and TreatmentMedicine

MeSH Terms

AnimalsAntibodies, MonoclonalImmunotoxinsAntineoplastic AgentsInterleukin-2Mycosis FungoidesSezary SyndromeSkin NeoplasmsUnited StatesLymphoma, T-Cell, CutaneousMice

Keywords

ImmunotoxinMedicineCancer researchCutaneous T-cell lymphomaCCR4Mycosis fungoidesBrentuximab vedotinBexaroteneLymphomaImmunologyInternal medicineChemistryReceptorCD30Tumor cellsMonoclonal antibodyAntibodyDiphtheria toxinAdcetrisCcr4-il2 Bispecific Immunotoxin

Sustainable Development Goals

SDG 0: Good health and well-being